Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health Stefania MaggiMelissa K. AndrewAnnemarijn de Boer Commentary Open access 23 November 2023 Pages: 413 - 420
Publisher Correction: Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health Stefania MaggiMelissa K. AndrewAnnemarijn de Boer Publisher Correction Open access 16 February 2024 Pages: 421 - 421
4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion Nguyen Phung Nguyen ThePham Quang ThaiNguyen Hoan Le Minh Commentary Open access 02 March 2024 Pages: 423 - 437
Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France Elise FoudratSophie Caillard Commentary Open access 08 March 2024 Pages: 439 - 445
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review Raunak ParikhMitra YousefiRobyn Widenmaier Review Open access 05 March 2024 Pages: 447 - 461
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019 Mariana HaebererRobin BruyndonckxElizabeth Begier Original Research Open access 06 February 2024 Pages: 463 - 480
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach Florian ZeevatJoost J. M. SimonsMaarten J. Postma Original Research Open access 16 February 2024 Pages: 481 - 499
A Population-Based Study on the Incidence, Risk Factors, and Outcome of Salmonella Bloodstream Infections in South Sweden 2012–2022 L. BjörklundY. MattissonO. Ljungquist Original Research Open access 23 February 2024 Pages: 501 - 519
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial F. D. Richard HobbsHugh MontgomeryMark T. Esser Original Research Open access 25 February 2024 Pages: 521 - 533
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement Nicholas W. Van HiseRussell M. PetrakMark Redell Original Research Open access 29 February 2024 Pages: 535 - 547
Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example Emma WarrenBelinda J. C. CastlesAitor Arteaga Original Research Open access 01 March 2024 Pages: 549 - 564
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study Nicholas ReboldSara AlosaimyMichael J. Rybak Original Research Open access 01 March 2024 Pages: 565 - 579
Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae Miri HyunJi Yeon LeeHyun ah Kim Original Research Open access 09 March 2024 Pages: 581 - 595
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor Takayuki KatsubeSafwan KezborRyuji Kubota Original Research Open access 09 March 2024 Pages: 597 - 607
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study Juan AmbrosioniNatalia Anahí DíazJose Molto Brief Report Open access 19 February 2024 Pages: 609 - 617
Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices Abiu SempereGabriela ChulloMarta Bodro Case Report Open access 23 February 2024 Pages: 619 - 624
Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen Federica PortunatoClaudia BartalucciMatteo Bassetti Case Report Open access 08 March 2024 Pages: 625 - 632